3-hydroxy-β-ionone | 116296-75-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 3-hydroxy-β-ionone
• 英文别名: (E)-4-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one；3-Hydroxy-β-jonon；3-Hydroxy-beta-ionone；(E)-4-(4-hydroxy-2,6,6-trimethylcyclohexen-1-yl)but-3-en-2-one
• CAS: 116296-75-4
• 化学式: C₁₃H₂₀O₂
• 分子量: 208.301
• InChiKey: HFRZSVYKDDZRQY-AATRIKPKSA-N

物化性质

• 沸点：
  105-110 °C(Press: 0.03 Torr)
• 密度：
  1.038±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-hydroxy-β-ionone 在 1,2-环氧丁烷 、 potassium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 二氯甲烷 、 水 、 乙酸乙酯 、 甲苯 为溶剂， 反应 29.5h， 生成 隐黄质
  参考文献：
  名称：

  （3S）-和（3R）-3-羟基-β-紫罗兰酮的合成及其向（3S）-和（3R）-β-隐黄质的转化

  摘要：

  （3R）-3-羟基-β-紫罗兰酮和（3S）-3-羟基-β-紫罗兰酮由对映体纯度高的市售（±）-α-紫罗兰酮合成。然后根据已知方法通过C 15 + C 10 + C 15 Wittig偶联策略将这些紫罗兰酮转化为（3 R）-β-隐黄质和（3 S）-β-隐黄质。这种方法可以极大地简化具有3-羟基-β-端基的旋光性类胡萝卜素的总合成，所述基团具有明显的生物活性。 羟基类胡萝卜素-类胡萝卜素前体-手性拆分-立体选择性合成-Wittig反应

  DOI：

  10.1055/s-0030-1258382
• 作为产物：
  描述：

  zeaxanthin 在 双氧水 、 sodium acetate 作用下， 以 水 为溶剂， 反应 1.0h， 生成 3-hydroxy-β-ionone
  参考文献：
  名称：

  Generation of Norisoprenoid Flavors from Carotenoids by Fungal Peroxidases

  摘要：

  To biotechnologically produce norisoprenoid flavor compounds, two extracellular peroxidases (MsP1 and MsP2) capable of degrading carotenoids were isolated from the culture supernatants of the basidiomycete Marasmius scorodonius (garlic mushroom). The encoding genes were cloned from genomic DNA and cDNA libraries, and databank homology searches identified MsP1 and MsP2 as members of the so-called "DyP-type" peroxidase family. Wild type enzymes and recombinant peroxidases expressed in Escherichia coli were employed for the release of norisoprenoids; from various terpenoid precursor molecules. Carotenes, xanthophylls, and apocarotenals were subjected to the enzymatic degradation. Released volatile products were characterized by GC-FID and GC-MS, whereas nonvolatile breakdown products were analyzed by means of HPLC-DAD and HPLC-MS. C13 norisoprenoids together with C10 products proved to be the main volatile degradation products in each case.

  DOI：

  10.1021/jf901438m

文献信息

• Retinoids and related compounds. X. Synthesis of geometrical isomers of (.+-.)-2- and (.+-.)-3-Hydroxyretinals and identification of the cromophore of the fly visual pigment.
  作者：MASAYOSHI ITO、NOZOMI MATSUOKA、KIYOSHI TSUKIDA、TAKAHARU SEKI

  DOI：10.1248/cpb.36.78

  日期：——

  The geometrical isomers of (±)-3-hydroxyretinals were synthesized and characterized. Subsequently, simultaneous separation of eight isomers of 2- and 3-hydroxyretinals by high-performance liquid chromatography (HPLC) was accomplished and, in addition, complete separation of eight syn-anti isomers of 3-hydroxyretinaloximes by HPLC was achieved. Under these analytical conditions, the chromophore of the fly (Drosphila melanogaster) visual pigment was identified as 11-cis-3-hydroxyretinal (10).

  合成了（±）-3-羟基视黄醛的几何异构体并对其进行了表征。随后，通过高效液相色谱（HPLC）同时分离了8种2-和3-羟基视黄醛的异构体，并且实现了8种顺-反异构体3-羟基视黄醛肟的完全分离。在这些分析条件下，果蝇（黑腹果蝇）视色素的发色团被鉴定为11-顺式-3-羟基视黄醛（10）。
• Unusually Broad Substrate Profile of Self-Sufficient Cytochrome P450 Monooxygenase CYP116B4 from<i>Labrenzia aggregata</i>
  作者：Yue-Cai Yin、Hui-Lei Yu、Zheng-Jiao Luan、Ren-Jie Li、Peng-Fei Ouyang、Jing Liu、Jian-He Xu

  DOI：10.1002/cbic.201402309

  日期：2014.11.3

  Catalytic versatility of P450LaMO: A new redox‐self‐sufficient P450 of the CYP116B subfamily was discovered by data mining. A substrate spectrum study showed that it was a catalytic versatile monooxygenase, mediating oxidation reactions as diverse as hydroxylation, alkene epoxidation, O‐dealkyl‐ ation, sulfoxidation, and even hydration.

  P450 La MO的催化多功能性：通过数据挖掘发现了一种新的氧化还原自足型CYP116B亚家族。底物光谱研究表明，它是一种催化型多功能单加氧酶，介导了各种氧化反应，包括羟基化，烯烃环氧化，O-脱烷基，硫氧化甚至水合。
• [EN] OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE<br/>[FR] LIGANDS DE LIAISON À L'OPSINE, COMPOSITIONS ET PROCÉDÉS D'UTILISATION
  申请人：BIKAM PHARMACEUTICALS INC

  公开号：WO2010147653A1

  公开（公告）日：2010-12-23

  Compounds and compositions of said compounds along with methods of use of compounds are disclosed for treating ophthalmic conditions related to mislocalization of opsin proteins, the misfolding of mutant opsin proteins and the production of toxic visual cycle products that accumulate in the eye. Compounds and compositions useful in the these methods, either alone or in combination with other therapeutic agents, are also described.

  本文披露了用于治疗与视蛋白蛋白质错位、突变视蛋白蛋白质的错误折叠以及在眼睛中积累的有毒视觉循环产物有关的眼科疾病的化合物及该化合物的组合物，以及使用该化合物的方法。还描述了在这些方法中有用的化合物和组合物，无论是单独使用还是与其他治疗剂联合使用。
• Process for Synthesis of (3S)- and (3R)-3-Hydroxy-Beta-Ionone, and Their Transformation to Zeaxanthin and Beta-Cryptoxanthin
  申请人：Khachik Frederick

  公开号：US20090311761A1

  公开（公告）日：2009-12-17

  (3R)-3-Hydroxy-β-ionone and (3S)-3-hydroxy-β-ionone are two important intermediates in the synthesis of carotenoids with β-end group such as lutein, zeaxanthin, β-cryptoxanthin, and their stereoisomers. Among the various stereoisomers of these carotenoids, only (3R,3′R,6′R)-lutein, (3R,3′R)-zeaxanthin, and (3R)-β-cryptoxanthin are present in commonly consumed fruits and vegetables. There are 3 possible stereoisomers for zeaxanthin, these are: dietary (3R,3′R)-zeaxanthin (1), non-dietary (3S,3′S)-zeaxanthin (2), and non-dietary (3R,3′S;meso)-zeaxanthin (3) which is a presumed metabolite of dietary lutein. Dietary lutein as well as 1 and 3 are accumulated in the human macula and have been implicated in the prevention of age-related macular degeneration. (3R)-β-Cryptoxanthin (4) is also present in selected ocular tissues at a very low concentration whereas its enantiomer (3S)-β-cryptoxanthin (5) is absent in foods and human plasma. The present invention relates to a process for the synthesis of (3R)-3-hydroxy-β-ionone and its (3S)-enantiomer in high optical purity from commercially available (rac)-α-ionone. The key intermediate for the synthesis of these hydroxyionones is 3-keto-α-ionone ketal that was prepared from (rac)-α-ionone after protection of this ketone as a 1,3-dioxolane. Reduction of 3-keto-α-ionone ketal followed by deprotection, lead to 3-hydroxy-α-ionone that was transformed into (rac)-3-hydroxy-β-ionone by base-catalyzed double bond isomerization in 46% overall yield from (rac)-α-ionone. The racemic mixture of these hydroxyionones was then resolved by enzyme-mediated acylation in 96% ee. (3R)-3-Hydroxy-β-ionone and its (3S)-enantiomer were respectively transformed to (3R)-3-hydroxy-(β-ionylideneethyl)triphenylphosphonium chloride [(3R)—C 15 -Wittig salt] and its (3S)-enantiomer [(3S)—C 15 -Wittig salt] according to known procedures. Double Wittig condensation of these Wittig salts with commercially available 2,5-dimethylocta-2,4,6-triene-1,8-dial provided all 3 stereoisomers of zeaxanthin (1-3). Similarly, (3R)—C 15 -Wittig and its (3S)-enantiomer were each coupled with β-apo-12′-carotenal to yield 4 and 5.

  (3R)-3-羟基-β-离子酮和(3S)-3-羟基-β-离子酮是合成带有β末端基团的类胡萝卜素如叶黄素、玉米黄质、β-隐黄素及其立体异构体的两个重要中间体。在这些类胡萝卜素的各种立体异构体中，只有(3R,3′R,6′R)-叶黄素、(3R,3′R)-玉米黄质和(3R)-β-隐黄素存在于常见的水果和蔬菜中。玉米黄质有3种可能的立体异构体，分别是：膳食(3R,3′R)-玉米黄质（1）、非膳食(3S,3′S)-玉米黄质（2）和非膳食(3R,3′S;meso)-玉米黄质（3），后者被认为是膳食叶黄素的代谢产物。膳食叶黄素以及1和3在人类黄斑中积累，并被认为有助于预防年龄相关性黄斑变性。 (3R)-β-隐黄素（4）也以极低浓度存在于选定的眼部组织中，而其对映异构体(3S)-β-隐黄素（5）在食物和人类血浆中不存在。本发明涉及一种从市售的（rac）-α-离子酮合成（3R）-3-羟基-β-离子酮及其（3S）对映体的高光学纯度的过程。合成这些羟基酮的关键中间体是从（rac）-α-离子酮制备的3-酮-α-离子酮缩酮，在保护该酮为1,3-二氧兰后得到。随后对3-酮-α-离子酮缩酮进行还原和去保护，得到3-羟基-α-离子酮，再经碱催化的双键异构化，从（rac）-α-离子酮中总产率为46%地转化为（rac）-3-羟基-β-离子酮。然后通过酶介导的酰化将这些羟基酮的外消旋混合物在96%纯度下分离。 (3R)-3-羟基-β-离子酮及其（3S）对映体分别按照已知程序转化为(3R)-3-羟基-(β-离子乙基)三苯基膦盐[(3R)—C15-Wittig盐]和其（3S）对映体[(3S)—C15-Wittig盐]。这些Wittig盐与市售的2,5-二甲基辛-2,4,6-三烯-1,8-二醛进行双Wittig缩合，提供了叶黄素的3种立体异构体（1-3）。类似地，(3R)—C15-Wittig及其（3S）对映体分别与β-脱氧-12'-类胡萝卜醛偶联，得到4和5。
• Process or synthesis of (3S)- and (3R)-3-hydroxy-beta-ionone, and their transformation to zeaxanthin and beta-cryptoxanthin
  申请人：University of Maryland, College Park

  公开号：US08222458B2

  公开（公告）日：2012-07-17

  Disclosed is a process for the synthesis of (3R)-3-hydroxy-β-ionone and its (3S)-enantiomer in high optical purity from commercially available (rac)-α-ionone. The key intermediate for the synthesis of these hydroxyionones is 3-keto-α-ionone ketal that was prepared from (rac)-α-ionone after protection of this ketone as a 1,3-dioxolane. Reduction of 3-keto-α-ionone ketal followed by deprotection, lead to 3-hydroxy-α-ionone that was transformed into (rac)-3-hydrox-β-ionone by base-catalyzed double bond isomerization in 46% overall yield from (rac)-α-ionone. The racemic mixture of these hydroxyionones was then resolved by enzyme-mediated acylation in 96% ee. (3R)-3-Hydroxy-β-ionone and its (3S)-enantiomer were respectively transformed to (3R)-3-hydroxy-(β-ionylideneethyl)triphenylphosphonium chloride [(3R)-C15-Wittig salt] and its (3S)-enantiomer [(3S)-C15-Wittig salt] according to known procedures. Double Wittig condensation of these Wittig salts with commercial available 2,5- dimethtylocta-2,4,6-triene-1,8-dial provided all 3 stereoisomers of zeaxanthin. Similarly, (3R)-C15-Wittig and its (3S)-enantiomer were each coupled with β-apo-12′-carotenal.

  本文披露了一种从商业可获得的（rac）-α-离子酮合成（3R）-3-羟基-β-离子酮及其（3S）对映体的高光学纯度的过程。合成这些羟基离子酮的关键中间体是从（rac）-α-离子酮制备的3-酮-α-离子酮缩酮，经过将该酮保护为1,3-二氧杂环后得到。还原3-酮-α-离子酮缩酮，然后去保护，得到3-羟基-α-离子酮，通过碱催化的双键异构化，从（rac）-α-离子酮中总产率为46%转化为（rac）-3-羟基-β-离子酮。这些羟基离子酮的混合物随后通过酶介导的酰化在96%的ee下分离。（3R）-3-羟基-β-离子酮及其（3S）对映体分别按照已知程序转化为（3R）-3-羟基-(β-离子基乙基)三苯基膦盐[(3R)-C15-Wittig盐]和其（3S）对映体[(3S)-C15-Wittig盐]。将这些Wittig盐与商业可获得的2,5-二甲基辛二烯-1,8-二醛进行双Wittig缩合，得到所有3种类脂黄素的立体异构体。类似地，（3R）-C15-Wittig及其（3S）对映体分别与β-脱氧-12'-类胡萝卜素醛偶联。